Gastrointestinal stromal tumor in Brazil: Clinicopathology, immunohistochemistry, and molecular genetics of 513 cases

Pathology International

Volumn 58, Issue 6, 2008, Pages 344-352

  Lopes, Lisandro Ferreira ^a,b   Ojopi, Elida B ^b   Bacchi, Carlos E ^a,b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Pathology Reference Laboratory   (Brazil)

^c Consultoria Em Patologia ^*  (Brazil)

Author keywords

Brazil; Clinicopathological study; Gastrointestinal stromal tumor; Immunohistochemistry; Mutation analysis; Tissue microarray

Indexed keywords

CD34 ANTIGEN; CD44V ANTIGEN; CD44V3 ANTIGEN; CELL SURFACE MARKER; DESMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN S 100; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; DEMOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX RATIO; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 43549097366     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02235.x     Document Type: Article

References (52)

1. Rubin BP. Gastrointestinal stromal tumours: An update. Histopathology 2006 48 : 83 96.
2. Miettinen M, Lasota J. Gastrointestinal stromal tumours. Review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006 130 : 1466 78.
3. Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996 111 : 492 515.
4. Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998 279 : 577 80.
5. Kindblom LG, Remotti HE, Aldenborg F et al. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998 153 : 1259 69.
6. Corless CL, McGreevey L, Haley A et al. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002 160 : 1567 72.
7. Heinrich MC, Corless CL, Duensing A et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003 299 : 708 10.
8. Medeiros F, Corless CL, Duensing A et al. KIT-negative gastrointestinal stromal tumors: Proof of concept and therapeutic implications. Am J Surg Pathol 2004 28 : 889 94.
9. Savage DG, Antman KH. Imatinib mesylate: A new oral targeted therapy. N Engl J Med 2002 346 : 683 93.
10. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000 24 : 211 22.
11. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005 29 : 52 68.
12. Miettinen M, Kopczynski J, Makhlouf HR et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003 27 : 625 41.
13. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006 30 : 477 89.
14. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000 24 : 1339 52.
15. Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: A clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 2001 25 : 1121 33.
16. Miettinen M, Monihan JM, Sarlomo-Rikala M et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: Clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999 23 : 1109 18.
17. Makar RR, al-Waheeb S, John B, Junaid TA. Gastrointestinal stromal tumors: Clinicopathological and immunohistochemical features. Med Princ Pract 2002 11 : 93 9.
18. Zepeda-Gomez S, Nuncio JF, Maldonado H et al. Gastrointestinal stromal tumors: Clinical and pathological analysis of 24 cases. Rev Invest Clin 2004 56 : 443 8.
19. Khoo JJ, Gunn A. A clinical and immunohistochemical study of gastrointestinal stromal tumours. Malays J Pathol 2005 27 : 9 16.
20. Liu FY, Qi JP, Xu FL, Wu AP. Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor. World J Gastroenterol 2006 12 : 4161 5.
21. Kim KM, Kang DW, Moon WS et al. Gastrointestinal stromal tumors in Koreans: Its incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci 2005 20 : 977 84.
22. Urbanczyk K, Limon J, Korobowicz E et al. Gastrointestinal stromal tumors. A multicenter experience. Pol J Pathol 2005 56 : 51 61.
23. Ueyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992 69 : 947 55.
24. Koay MH, Goh YW, Iacopetta B et al. Gastrointestinal stromal tumours (GISTs): A clinicopathological and molecular study of 66 cases. Pathology 2005 37 : 22 31.
25. Li CF, Chuang SS, Lu CL, Lin CN. Gastrointestinal stromal tumor (GIST) in southern Taiwan: A clinicopathologic study of 93 resected cases. Pathol Res Pract 2005 201 : 1 9.
26. Orosz Z, Tornoczky T, Sapi Z. Gastrointestinal stromal tumors: A clinicopathologic and immunohistochemical study of 136 cases. Pathol Oncol Res 2005 11 : 11 21.
27. Alvarado-Cabrero I, Vazquez G, Sierra Santiesteban FI, Hernandez-Hernandez DM, Pompa AZ. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: The experience at 3 large medical centers in Mexico. Ann Diagn Pathol 2007 11 : 39 45.
28. Wang X, Mori I, Tang W et al. Gastrointestinal stromal tumors: Clinicopathological study of Chinese cases. Pathol Int 2001 51 : 701 6.
29. Fletcher CD, Berman JJ, Corless C et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002 33 : 459 65.
30. Liebermann DA, Hoffman B, Vesely D. p53 induced growth arrest versus apoptosis and its modulation by survival cytokines. Cell Cycle 2007 6 : 166 70.
31. Sy MS, Mori H, Liu D. CD44 as a marker in human cancers. Curr Opin Oncol 1997 9 : 108 12.
32. Daum O, Klecka J, Ferda J et al. Gastrointestinal stromal tumor of the pancreas: Case report with documentation of KIT gene mutation. Virchows Arch 2005 446 : 470 72.
33. Lee CH, Lin YH, Lin HY, Lee CM, Chu JS. Gastrointestinal stromal tumor of the prostate: A case report and literature review. Hum Pathol 2006 37 : 1361 5.
34. Herawi M, Montgomery EA, Epstein JI. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases. Am J Surg Pathol 2006 30 : 1389 95.
35. Irving JA, Lerwill MF, Young RH. Gastrointestinal stromal tumors metastatic to the ovary: A report of five cases. Am J Surg Pathol 2005 29 : 920 26.
36. Reith JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 2000 13 : 577 85.
37. Mikhael AI, Bacchi CE, Zarbo RJ et al. CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem 1994 2 : 89 93.
38. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A et al. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998 11 : 728 34.
39. Cai YC, Jiang Z, Vittimberga F et al. Expression of transforming growth factor-alpha and epidermal growth factor receptor in gastrointestinal stromal tumours. Virchows Arch 1999 435 : 112 15.
40. Lanzafame S, Minutolo V, Caltabiano R et al. About a case of GIST occurring during pregnancy with immunohistochemical expression of epidermal growth factor receptor and progesterone receptor. Pathol Res Pract 2006 202 : 119 23.
41. Yoo NJ, Lee JW, Soung YH et al. Mutational analysis of the epidermal growth factor receptor gene in gastrointestinal stromal tumors. J Korean Gastric Cancer Assoc 2004 4 : 268 71.
42. Tornillo L, Duchini G, Carafa V et al. Patterns of gene amplification in gastrointestinal stromal tumors (GIST). Lab Invest 2005 85 : 921 31.
43. Yang Y, Ikezoe T, Nishioka C et al. ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib. Cancer Sci 2006 97 : 1404 9.
44. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002 33 : 669 76.
45. Sabah M, Cummins R, Leader M, Kay E. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: Markers with potential prognostic implications. Hum Pathol 2006 37 : 648 55.
46. Feakins RM. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome. Histopathology 2005 46 : 270 79.
47. Seidal T, Edvardsson H. Expression of c-kit (CD117) and Ki-67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours. Histopathology 1999 34 : 416 24.
48. Hu TH, Chuah SK, Lin JW et al. Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese. World J Gastroenterol 2006 12 : 595 602.
49. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997 28 : 160 65.
50. Nakamura N, Yamamoto H, Yao T et al. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol 2005 36 : 828 37.
51. Yalcinkaya U, Yerci O, Koc EU. Significance of p53 expression in gastrointestinal stromal tumors. Hepatogastroenterology 2007 54 : 140 43.
52. Montgomery E, Abraham SC, Fisher C et al. CD44 loss in gastric stromal tumors as a prognostic marker. Am J Surg Pathol 2004 28 : 168 77.